Nucynta and Benicar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nucynta (tapentadol hydrochloride) and Benicar (olmesartan medoxomil). Common drug interactions include hallucination among females and muscular weakness among males.

The phase IV clinical study analyzes what interactions people have when they take Nucynta and Benicar. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Nucynta?

Nucynta has active ingredients of tapentadol hydrochloride. It is often used in pain. eHealthMe is studying from 31,818 Nucynta users. Check the latest studies of Nucynta.

What is Benicar?

Benicar has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 36,002 Benicar users. Check the latest studies of Benicar.



On Jul, 14, 2026

41 people who take Nucynta and Benicar together, and have interactions are studied.

Nucynta and Benicar drug interactions.

What are the common drug interactions of Nucynta and Benicar, by gender? *:

female:

  1. Hallucination (an experience involving the perception of something not present)
  2. Psychotic disorder
  3. Somnolence (a state of near-sleep, a strong desire for sleep)
  4. Discomfort
  5. Drug hypersensitivity
  6. Fatigue (feeling of tiredness)
  7. Adnexa uteri pain
  8. Bacteriuria (presence of bacteria in urine)
  9. Balance disorder
  10. Blood urea increased

male:

  1. Muscular weakness (muscle weakness)
  2. Chest pain
  3. Diarrhoea
  4. Suicidal ideation
  5. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  6. Nephrogenic anaemia (anaemia due to kidney disease)
  7. Appetite disorder (abnormal eating habits)
  8. Blindness
  9. Cardiac murmur (an heart sound in valve abnormality)
  10. Cataract (clouding of the lens inside the eye)

What are the common drug interactions of Nucynta and Benicar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Injection site urticaria (rash of round, red welts on the skin at injection site)
  2. Lupus-like syndrome (a disease symptom matches with lupus an immune disease)
  3. Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
  4. Surgical failure

40-49:

  1. Depression
  2. Suicidal ideation
  3. Adnexa uteri pain
  4. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  5. Anxiety
  6. Diarrhoea
  7. Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Ovarian cyst (fluid filled sac of the ovary)
  10. Ovarian cyst ruptured (tear in fluid filled sac of the ovary)

50-59:

  1. Drug hypersensitivity
  2. Discomfort
  3. Dysphonia (speech disorder attributable to a disorder of phonation)
  4. Hepatic enzyme increased
  5. Oropharyngeal pain
  6. Somnolence (a state of near-sleep, a strong desire for sleep)

60+:

  1. Muscular weakness (muscle weakness)
  2. Chest pain
  3. Somnolence (a state of near-sleep, a strong desire for sleep)
  4. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  5. Renal failure (kidney dysfunction)
  6. Appetite disorder (abnormal eating habits)
  7. Blindness
  8. Cardiac murmur (an heart sound in valve abnormality)
  9. Cataract (clouding of the lens inside the eye)
  10. Contusion (a type of hematoma of tissue in which capillaries)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 26.83%
  2. Chest Pain: 7 people, 17.07%
  3. Prostate Cancer: 6 people, 14.63%
  4. Asthma: 5 people, 12.20%
  5. Procedural Pain: 4 people, 9.76%
  6. Neuralgia (pain in one or more nerves): 4 people, 9.76%
  7. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 9.76%
  8. High Blood Cholesterol: 4 people, 9.76%
  9. Diabetes: 4 people, 9.76%
  10. Depression: 4 people, 9.76%

* Approximation only. Some reports may have incomplete information.

Do you take Nucynta and Benicar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nucynta and Benicar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nucynta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Benicar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nucynta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Benicar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tapentadol hydrochloride and olmesartan medoxomil (the active ingredients of Nucynta and Benicar, respectively), and Nucynta and Benicar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: